USA - NASDAQ:IMTX - NL0015285941 - Common Stock
ChartMill assigns a Buy % Consensus number of 87% to IMTX. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-18 | Guggenheim | Initiate | Buy |
| 2025-05-28 | Deutsche Bank | Initiate | Buy |
| 2025-04-01 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-19 | B of A Securities | Maintains | Buy -> Buy |
| 2024-10-07 | Piper Sandler | Initiate | Overweight |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-05 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-05-16 | Mizuho | Maintains | Buy -> Buy |
| 2023-11-02 | Cantor Fitzgerald | Initiate | Overweight |
| 2023-03-31 | Mizuho | Initiate | Buy |
| 2023-03-23 | Chardan Capital | Maintains | Buy |
| 2022-08-10 | Chardan Capital | Maintains | Buy |
| 2022-06-03 | SVB Leerink | Maintains | Outperform |
| 2021-07-15 | SVB Leerink | Maintains | Outperform |
| 2021-03-17 | SVB Leerink | Maintains | Outperform |
17 analysts have analysed IMTX and the average price target is 16.12 USD. This implies a price increase of 78.08% is expected in the next year compared to the current price of 9.05.
The consensus rating for IMMATICS NV (IMTX) is 87.0588 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering IMMATICS NV (IMTX) is 17.